Medicine and Dentistry
Familial Hypercholesterolemia
100%
Sex Difference
56%
Cardiovascular System
40%
Low Density Lipoprotein Cholesterol
40%
Family Planning
37%
Cardiovascular Risk
36%
Monoclonal Antibody
24%
Infection
18%
Pyoderma gangrenosum
18%
Lipid Metabolism
18%
Inclisiran
18%
Glomerulopathy
18%
Lipoprotein
18%
Prospective Study
18%
Arteriosclerotic Heart Disease
16%
Kexin
16%
Subtilisin
16%
Serine Proteinase
16%
Statin
11%
Familial Dysbetalipoproteinemia
7%
Conception
7%
Myocardial Infarction
6%
Antibiotic Therapy
6%
Venous Ulcer
6%
Gestational Diabetes
6%
Growth, Development and Aging
6%
Dyslipidemia
6%
Large for Gestational Age
6%
Fetus Growth
6%
Fetus Development
6%
Premature Labor
6%
Metabolic Syndrome
6%
High Density Lipoprotein Cholesterol
6%
Pre-Eclampsia
6%
Triacylglycerol
6%
Adverse Outcome
6%
Hyperlipidemia
6%
High Risk Population
6%
Human Milk
6%
Proprotein Convertase 9
5%
Ascorbic Acid
5%
Side Effect
5%
Pharmacology, Toxicology and Pharmaceutical Science
Familial Hypercholesterolemia
84%
Low Density Lipoprotein Cholesterol
75%
Coronary Artery Atherosclerosis
49%
Cardiovascular Risk
40%
Triacylglycerol
28%
High Density Lipoprotein Cholesterol
28%
Monoclonal Antibody
24%
Hydroxymethylglutaryl Coenzyme A Reductase Inhibitor
21%
Cardiovascular Disease
20%
Lipoprotein
20%
Inclisiran
18%
Glomerulopathy
18%
Lipoprotein A
18%
Kexin
16%
Serine Proteinase
16%
Subtilisin
16%
Metabolic Syndrome X
9%
Dyslipidemia
9%
Hyperlipidemia
9%
Pregnancy Diabetes Mellitus
9%
Premature Labor
9%
Adverse Outcome
9%
Preeclampsia
9%
Large for Gestational Age
9%
Hyperlipoproteinemia Type 3
7%
Heart Infarction
6%
Proprotein Convertase 9
5%
Ascorbic Acid
5%
Side Effect
5%
Nursing and Health Professions
Familial Hypercholesterolemia
37%
Health Care Personnel
28%
Proprotein Convertase 9
24%
Quality of Life
18%
Inclisiran
18%
Family Planning
18%
Shared Decision-Making
9%
Low Density Lipoprotein Cholesterol Level
8%
Low Density Lipoprotein Cholesterol
7%
Cardiovascular Disease
6%
Monoclonal Antibody
5%
Clinical Practice
5%
